SMN1 and retinitis pigmentosa 1: Nrf2 inhibitor inhibited the effects of Oroxylin A on inflammation, oxidative stress, and col3a1/FN/sma/twist mRNA expressions in the in vitro model of RP (Figures 8(b), 8(c), 8(d), 8(e)).